MIS-C is a serious immune-mediated response to COVID-19 infection
Pediatric News ,
A reliable profile of MIS-C is only beginning to emerge from the series of published case series, most of which have only…
Showing items 1–100
Tackling the unknowns of long-haul COVID-19
Hutch News,
Finding the right box Another major challenge that long COVID-19 researchers face is classification.
Por qué el sistema inmunológico de los niños estaría mejor equipado para luchar contra el coronavirus
infobae,
Los más chicos representan solo un pequeño porcentaje de las infecciones por COVID-19, una tendencia que ha desconcertado a los…
Multisystem inflammatory syndrome in children remains a rare but serious complication associated with SARS-CoV-2 infection | 2 Minute Medicine
2 Minute Medicine ,
1. In this cohort study, multisystem inflammatory syndrome in children was a rare but serious complication associated with SARS-C…
Mucocutaneous Symptoms Common in Children Hospitalized With Suspected MIS-C
Medscape,
NEW YORK (Reuters Health) - Mucocutaneous symptoms were common in multisystem inflammatory syndrome in children (MIS-C) during…
O que está a proteger as crianças da Covid-19?
Sabado Portugal,
Devido ao forte sistema imunitário de crianças, o coronavírus é rapidamente reconhecido e eliminado.
Operational and Financial Results for the Period Ended September 30, 2020
IT Business Net,
@media screen and (min-width: 1201px) {.jlcof5fb78d5ced102 { display: block; } } @media screen and (min-width: 993px) and (max-wi…
Operational and Financial Results for the Period Ended September 30, 2020
Jotup,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
Spoke,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
One News Page,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
One News Page,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
How Major US Stock Indexes Fared Thursday
Yahoo! Finance USA,
GlobeNewswire Operational and Financial Results for the Period Ended September 30, 2020 NEW YORK, Nov.
Operational and Financial Results for the Period Ended September 30, 2020
Biz Wire Express,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Natural Grocers: Fiscal 4Q Earnings Snapshot
Yahoo! Finance Canada ,
GlobeNewswire Operational and Financial Results for the Period Ended September 30, 2020 NEW YORK, Nov.
Mnuchin rejects renewal of some Fed emergency loan programs
Yahoo! Finance Canada ,
GlobeNewswire Operational and Financial Results for the Period Ended September 30, 2020 NEW YORK, Nov.
Operational and Financial Results for the Period Ended September 30, 2020
Crwe World,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
TMCnet.com,
] NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
Stockwatch,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
Morning Star,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
GlobeNewswire,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Operational and Financial Results for the Period Ended September 30, 2020
Yahoo! Finance USA,
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular…
Mesoblast : MSB Q1 Financial Results and Operational Highlights
MarketScreener,
OPERATIONAL AND FINANCIAL RESULTS FOR THE PERIOD ENDED SEPTEMBER 30, 2020 Melbourne, Australia, November 20, and New York, USA…
What we can learn from COVID-19 in kids
Medium US,
Anyone can publish on Medium per our Policies, but we don’t fact-check every story.
Doctors chase treatment for kids threatened by dangerous COVID-19 syndrome
MSN,
On a warm, mid-June afternoon a concerned mother brought her 11-year-old daughter, who had a high fever and a severe bellyache…
Doctors Chase Treatment for Kids Threatened by Dangerous COVID-19 Syndrome
Scientific American,
On a warm, mid-June afternoon a concerned mother brought her 11-year-old daughter, who had a high fever and a severe bellyache…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
BioTech Gate,
Mesoblast Well Prepared Ahead of First Potential US Product Launch NEW YORK, Aug.
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020Mesoblast Well Prepared Ahead of First Potential US Product Launch
BioSpace,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
ValueSpectrum,
Mesoblast Well Prepared Ahead of First Potential US Product Launch NEW YORK, Aug.
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Jotup,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Biz Wire Express,
Mesoblast Well Prepared Ahead of First Potential US Product Launch NEW YORK, Aug.
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
One News Page,
Mesoblast Well Prepared Ahead of First Potential US Product Launch NEW YORK, Aug.
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
One News Page,
Mesoblast Reports Substantial Operational Progress and Mesoblast Well Prepared Ahead of First Potential US Product Launch NEW…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Crwe World,
Mesoblast Well Prepared Ahead of First Potential US Product Launch NEW YORK, Aug.
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Wall Street Online Denmark,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Stockwatch,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Morning Star,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
Benzinga,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:, ASX: MSB)) today reported operational highlights and…
Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020
GlobeNewswire,
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights…
NIH-funded Project Wants to Identify Children at Risk for MIS-C From COVID-19
Diagnostic and Interventional Cardiology,
August 7, 2020 — The National Institutes of Health (NIH) announced research funding to encourage the development of approaches…
¿La pandemia despertó un nuevo trastorno inflamatorio infantil?
infobae,
El especialista Michael Levin, de la sección de Enfermedades Infecciosas Pediátricas del Imperial College de Londres ha lanzado…
MIS-C is a serious immune-mediated response to COVID-19 infection
Pediatric News ,
One of the take-away messages from a review of multisystem inflammatory syndrome in children (MIS-C) is that clinicians…
Coronavirus Cuomo on MIS-C: “The more you look for it, the more you find it"
ABC 7 WKBW Buffalo,
ALBANY, N.Y. (WKBW) — New York state is investigating 242 cases of Multisystem Inflammatory Syndrome in Children, also known as…
MIL-OSI USA: Cracking Down on Compliance Violations
Foreign Affairs New Zealand,
Source: US State of New York Governor Andrew M. Cuomo today announced that 27 additional establishments have been issued State…
27 Additional State Liquor Authority Violations Issued
EIN Newsdesk,
Governor Andrew M. Cuomo today announced that 27 additional establishments have been issued State Liquor Authority violations…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
Jotup,
Although the FDA will consider the recommendation of the panel, the final decision regarding the approval of the product is…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
Spoke,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
Biz Wire Express,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
VB Profiles,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
FDA Advisory Committee Sets Review Date for Mesoblast's remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
TMCnet.com,
] NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
Crwe World,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
FDA Advisory Committee Sets Review Date for Mesoblast ’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
Stockwatch,
NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs…
FDA Advisory Committee Sets Review Date for Mesoblast's remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
MarketScreener,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
Morning Star,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host ...
EINPresswire,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
Should schools reopen amid the pandemic?
MSN,
_.
FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease
GlobeNewswire,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC…
15 L.A. County children sickened by rare coronavirus-related inflammatory syndrome
East Bay Times,
By Rong-Gong Lin II | Los Angeles Times A rare but serious and potentially deadly inflammatory syndrome believed to be…
L.A. County kids sickened by coronavirus-related syndrome
Danilposh,
A uncommon however critical and probably lethal inflammatory syndrome believed to be related to the coronavirus has now been…
News story from Los Angeles Times on Sunday 19 July 2020
Los Angeles Times,
15 L.A. County children sickened by rare coronavirus-related inflammatory syndrome
Yahoo! News,
A rare but serious and potentially deadly inflammatory syndrome believed to be associated with the coronavirus has now been…
Should schools reopen amid the pandemic?
MSN,
_.
Here’s What Parents Need to Know About Kawasaki Disease, Multisystem Inflammatory Syndrome, and COVID-19
MSN,
_.
Here’s What Parents Need to Know About Multisystem Inflammatory Syndrome and COVID-19
Pressfrom,
Over the past few months, at least 1,000 children have been diagnosed with a strange syndrome associated with COVID-19.
Here’s What Parents Need to Know About Kawasaki Disease, Multisystem Inflammatory Syndrome, and COVID-19
Fatherly,
Over the past few months, at least 1,000 children have been diagnosed with a strange syndrome associated with COVID-19.
Here’s What Parents Need to Know About Multisystem Inflammatory Syndrome and COVID-19
MSN,
_.
News story from Stat News on Thursday 16 July 2020
Stat News,
Coronavirus-related illness can be dangerous to children. What SC parents should know
Myrtle Beach,
July 14, 2020 05:00 AM Just weeks before the new academic year is set to begin, South Carolina still sits in uncertainty…
Coronavirus-related illness can be dangerous to children. What SC parents should know
The Island Packet,
Just weeks before the new academic year is set to begin, South Carolina still sits in uncertainty, facing one of the worst COVID…
Coronavirus-related illness can be dangerous to children. What SC parents should know
The Herald,
Just weeks before the new academic year is set to begin, South Carolina still sits in uncertainty, facing one of the worst COVID…
Coronavirus-related illness can be dangerous to children. What SC parents should know
The Charlotte Observer,
Just weeks before the new academic year is set to begin, South Carolina still sits in uncertainty, facing one of the worst COVID…
Coronavirus-related illness can be dangerous to children. What SC parents should know
Raleigh News and Observer ,
Just weeks before the new academic year is set to begin, South Carolina still sits in uncertainty, facing one of the worst COVID…
MIS-C not seen as significant threat in NH for young students
The Keene Sentinel ,
With recent pressure and planning to open public schools to in-person learning by the end of summer, the safety of children…
COVID-19 and children: What we know, what we don’t
Politifact,
Mid-to-late July is usually a time when American families gear up for a new school year.
MIS-C not seen as significant threat in Granite State for children
Concord Monitor,
This 2020 electron microscope image shows the spherical coronavirus particles from the first U.S.
News story from Wired.co.uk on Friday 10 July 2020
Wired.co.uk,
These children had Covid-19 beat. Then they got seriously ill
Google News,
Getty Images / WIRED Patrick Davies’ phone wouldn’t stop buzzing. It was April 24 and Davies, a consultant in paediatric…
These children had Covid-19 beat. Then they got seriously ill
Medical Health News,
/ WIRED P atrick Davies’ phone wouldn’t stop buzzing. It was April 24 and Davies, a consultant in paediatric intensive care at…
Multisystem Inflammatory Syndrome And COVID-19: What Parents Need To Know
MSN,
For a stretch last spring, national headlines were dominated by the disturbing news that children — who’d previously been…
Multisystem Inflammatory Syndrome in Children Profiled
Physician's Briefing,
(HealthDay News) -- Multisystem inflammatory syndrome in children (MIS-C), which coincided with COVID-19, is described in…
Multisystem Inflammatory Syndrome in Children Profiled
Drugs.com,
-- Multisystem inflammatory syndrome in children (MIS-C), which coincided with COVID-19, is described in children and…
Maine Voices: We know how to (relatively) safely reopen schools. Now we need the will, resources
Kennebec Journal & Morning Sentinel,
Frequent testing will be critical to protecting the health of teachers, students and families.
Maine Voices: We know how to (relatively) safely reopen schools. Now we need the will, resources
Portland Press Herald,
CUMBERLAND — No one disagrees that we need to reopen schools. The question is, can we do it safely? We need to minimize the…
Unpacking the mystery of MIS-C
Medical Health News,
A troubling rise in a severe inflammatory illness related to COVID-19 in children and young adults has doctors in the United…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With …
TMCnet.com,
] NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
BioSpace,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
MESOBLAST LIMITED : - EAP for Remestemcel-L in Children with MIS-C due to COVID-19
MarketScreener,
Melbourne - Mesoblast Limited (ASX: MSB; Nasdaq: MESO ) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
BioTech Gate,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Jotup,
Patients aged between two months and 17 years may receive one or two doses of remestemcel-L within five days of referral under…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Biz Wire Express,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
VB Profiles,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Crwe World,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Stockwatch,
NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Benzinga,
(GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:, ASX:MSB)) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
EIN Newsdesk,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome ...
EINPresswire,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Morning Star,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
Yahoo! Finance USA,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome Associated With COVID-19
GlobeNewswire,
(GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that an expanded access protocol (EAP) has been…
Diagnostic criteria may miss some MIS-C cases, experts say
Pediatric News ,
New data from active surveillance of the severe inflammatory condition associated with COVID-19 in previously healthy children…
Diagnostic Criteria May Miss Some MIS-C Cases, Experts Say
Medscape,
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Showing items 1–100